Skip to main content
SYK logo

SYK · Stryker Corp

Track SYK — free
Market Cap
$118.14B
Shares
383.57M

SYK metrics

94 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$303.13
Market cap
$118.14B

Price action

19 metrics
Price change (1W)
-4.4%
Price change (30D)
-8.7%
Price change (3M)
+2.3%
Price change (6M)
-16.9%
Price change (YTD)
-12.4%
Price change (1Y)
-20.7%
Trailing year
Price change (5Y)
+11.3%
52-week high
$394.34
52-week low
$282.58
Change from 52-week high
-21.9%
Change from 52-week low
+9.0%
Annualized volatility
28.1%
Beta
0.2
RSI (14D)
36.4
Price vs SMA 50
-6.4%
Price vs SMA 200
-9.1%
Avg volume (3M)
2.44M
Relative volume
1.1
Average dollar volume
$792.47M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
383.57M

Valuation

12 metrics
P / E (TTM)
31.9
Trailing earnings · reciprocal yield 3.1%
PEG ratio
0.7
EV / revenue
5.0×
reciprocal yield 19.9%
EV / EBITDA
18.1×
reciprocal yield 5.5%
EV / EBIT
23.4×
reciprocal yield 4.3%
P / sales
4.6×
reciprocal yield 21.9%
P / book
4.9
reciprocal yield 20.3%
FCF yield
4.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
25.1
reciprocal yield 4.0%
P / operating cash flow
21.4
reciprocal yield 4.7%
Earnings yield
3.2%

Historical valuation

8 metrics
P / E historical average (3Y)
41.8×
reciprocal yield 2.4%
P / E historical average (5Y)
42.5×
reciprocal yield 2.4%
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
1.1%
Trailing 12 months
Payout ratio
35.3%
Shareholder yield
Dividend / share (TTM)
$3.48
Dividend growth YoY
+4.8%
Dividend growth streak
5
Last ex-dividend
2026-06-30

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
65.0%
Operating margin
21.4%
Trailing 12 months
Net margin
14.4%
Gross profit (TTM)
$16.79B
Operating profit (TTM)
$5.53B
Net income (TTM)
$3.73B
Trailing 12 months
Diluted EPS (TTM)
$9.65
FCF margin
18.2%
Effective tax rate
27.6%

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$62.54

Growth

11 metrics
Revenue growth YoY
+9.4%
Year over year
Net income growth YoY
+44.3%
Revenue (TTM)
$25.84B
Trailing 12 months
EPS growth YoY
+44.1%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.8%
Revenue CAGR (5Y)
+11.8%
EPS CAGR (3Y)
+10.8%
EPS CAGR (5Y)
+14.9%
FCF CAGR (3Y)
+28.1%
FCF CAGR (5Y)
+9.0%

Quality

14 metrics
Return on equity
15.5%
Return on assets
7.8%
Debt / equity
0.6
Current ratio
2.2
EBITDA (TTM)
$7.16B
Free cash flow (TTM)
$4.70B
Quick ratio
1.3
Interest coverage
Net debt / EBITDA
1.6
Return on invested capital
11.3%
Trailing 12 months
Net cash
−$11.55B
Latest balance sheet
Cash & equivalents
$3.39B
Total assets
$47.93B
Total debt
$14.94B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.53B
Capital expenditures (TTM)
$823.00M
R&D (TTM)
$1.66B
SG&A (TTM)
$8.78B
Stock compensation (TTM)
$251.00M
R&D / revenue
6.4%
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
2,269
13F filer change QoQ
-46
Institutional ownership
81.0%

Short interest

3 metrics
Short interest
1.8%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
38 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$118.20M
Insider-sentiment score
13 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 310764 CUSIP 863667101 13F (30d) 1096 filings 1037 filers Visit website Investor relations